|
WO2020229584A1
|
|
Method for reducing methionine oxidation in recombinant proteins
|
|
WO2019020777A1
|
|
Liquid formulation of a vegf antagonist
|
|
EP3630043A1
|
|
Sterilizable pre-filled pharmaceutical packages comprising a liquid formulation of a vegf-antagonist
|
|
WO2018215580A1
|
|
Method for sterilizing prefilled plastic syringes containing a vegf antagonist
|
|
WO2018024770A1
|
|
Production of biosimilar ustekinumab in cho cells
|
|
EP3407868A1
|
|
Liquid formulation of a vegf antagonist
|
|
AU2016356047A1
|
|
Pre-filled plastic syringe containing a VEGF antagonist
|
|
AU2016358111A1
|
|
Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist
|
|
EP3143044A1
|
|
Pre-filled plastic syringe containing a vegf antagonist
|
|
EP3071181A1
|
|
Pharmaceutical composition of an anti-vegf antibody
|
